What is the price-to-earnings ratio of Nanobiotix?
The price-earnings ratio of Nanobiotix is currently 11.58.
Nanobiotix P/S 2024
Nanobiotix P/S
11.58
Ticker
NANO.PA
ISIN
FR0011341205
WKN
A1J7EB
As of Nov 29, 2024, Nanobiotix's P/S ratio stood at 11.58, a 93.65% change from the 5.98 P/S ratio recorded in the previous year.
The Nanobiotix P/S history
Nanobiotix Aktienanalyse
What does Nanobiotix do?
Nanobiotix SA is a biotechnology company specializing in the development of nanoparticles used in cancer therapy to increase the effectiveness of radiation therapy. It was founded in 2003 in Paris, France by Dr. Laurent Lévy and his team. The company went public in 2012 and is currently listed on the Euronext Paris exchange. Nanobiotix's business model is based on the production and marketing of nanoparticles called NBTXR3, which enhance the effectiveness of radiation therapy. The company works with various partners to further develop its technology and explore new applications. Nanobiotix has two main divisions: one focused on developing nanoparticles to enhance radiation therapy for cancer, and another dedicated to using nanoparticles as drug carriers. Its flagship product, NBTXR3, is designed specifically for cancer therapy and has shown promising results. Nanobiotix is also working on combining NBTXR3 with immunotherapies to further improve cancer treatment. In summary, Nanobiotix is an innovative company specializing in the development of nanoparticles to enhance radiation therapy for cancer and improve patient treatment. Nanobiotix ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Nanobiotix's P/S Ratio
Nanobiotix's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Nanobiotix's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Nanobiotix's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Nanobiotix’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Nanobiotix stock
How has the price-earnings ratio of Nanobiotix changed compared to last year?
The price-to-earnings ratio of Nanobiotix has increased by 93.65% increased compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Nanobiotix high compared to other companies?
Yes, the price-to-earnings ratio of Nanobiotix is high compared to other companies.
How does an increase in the price-earnings ratio of Nanobiotix affect the company?
An increase in the price-earnings ratio of Nanobiotix would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Nanobiotix affect the company?
A decrease in the price-earnings ratio of Nanobiotix would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Nanobiotix?
Some factors that influence the price-earnings ratio of Nanobiotix are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Nanobiotix pay?
Over the past 12 months, Nanobiotix paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Nanobiotix is expected to pay a dividend of 0 EUR.
What is the dividend yield of Nanobiotix?
The current dividend yield of Nanobiotix is .
When does Nanobiotix pay dividends?
Nanobiotix pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Nanobiotix?
Nanobiotix paid dividends every year for the past 0 years.
What is the dividend of Nanobiotix?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Nanobiotix located?
Nanobiotix is assigned to the 'Health' sector.
Wann musste ich die Aktien von Nanobiotix kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Nanobiotix from 11/29/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 11/29/2024.
When did Nanobiotix pay the last dividend?
The last dividend was paid out on 11/29/2024.
What was the dividend of Nanobiotix in the year 2023?
In the year 2023, Nanobiotix distributed 0 EUR as dividends.
In which currency does Nanobiotix pay out the dividend?
The dividends of Nanobiotix are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Nanobiotix stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Nanobiotix
Our stock analysis for Nanobiotix Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nanobiotix Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
